Sensoreal News
Sensoreal’s technology features in Nature Publications !
As a spin-off of the Juncker lab at McGill, we are excited to share that our technology was featured in the Nature journal! This milestone was a result of more than ten years of work by some of the most innovative individuals in the microfluidics field; our team will ardently continue to push the frontiers of point-of-care testing and bring this technology in the hands of the public.
As a spin-off of the Juncker lab at McGill, we are excited to share that our technology was featured in the Nature journal! This milestone was a result of more than ten years of work by some of the most innovative individuals in the microfluidics field; our team will ardently continue to push the frontiers of point-of-care testing and bring this technology in the hands of the public. The manuscript was published by the Juncker lab from which the published technology is licensed from. A summary of the technology has also been highlighted in the news section of the journal, which can be found on: A lab-on-a-chip that takes the chip out of the lab.
Sensoreal’s team happily welcomes two new additions
Sensoreal’s team happily welcomes two new additions. Ora Cohen joins as an Associate Scientist. Ora is a recent Bioengineering graduate from McGill University and has a strong biotechnology background alongside a solid understanding of medical device regulatory requirements. Sensoreal equally welcomes Samantha Rocher who will be joining the team as a Lab Assistant for a summer internship. Samantha is currently in her 3rd year in Biongineering at McGill University.
Sensoreal’s team happily welcomes two new additions. Ora Cohen joins as an Associate Scientist. Ora is a recent Bioengineering graduate from McGill University and has a strong biotechnology background alongside a solid understanding of medical device regulatory requirements. Sensoreal equally welcomes Samantha Rocher who will be joining the team as a Lab Assistant for a summer internship. Samantha is currently in her 3rd year in Biongineering at McGill University.
Sensoreal wins McGill Clinical Innovation Competition
Sensoreal wins at the annual McGill Clinical Innovation Competition. Demonstrating the capabilities of the microfluidics platform, Sensoreal’s team impressed the judge panel and took the prestigious MI4 Innovation Prize.
Sensoreal wins at the annual McGill Clinical Innovation Competition. Demonstrating the capabilities of the microfluidics platform, Sensoreal’s team impressed the judge panel and took the prestigious MI4 Innovation Prize.
Sensoreal top finalist in the Spring Impact Program
Sensoreal is proud to be top 10 finalist in the Spring Impact program. Link
Sensoreal is proud to be top 10 finalist in the Spring Impact program.
Sensoreal announce Pooya Saberi to CEO
Sensoreal is pleased to announce the appointment of Pooya Saberi to Chief Executive Officer. Pooya previously served as the company’s CPO, having joined during an exciting time of growth and transformation, and through his stellar performance Sensoreal has met and overcome numerous challenges. Sensoreal has ambitious mission and goals, and Pooya will continue to build the organization and bring it to the next level, providing strategic guidance and leadership for our in vitro diagnostic device R&D, regulatory approval, and commercialization teams.
Sensoreal is pleased to announce the appointment of Pooya Saberi to Chief Executive Officer. Pooya previously served as the company’s CPO, having joined during an exciting time of growth and transformation, and through his stellar performance Sensoreal has met and overcome numerous challenges. Sensoreal has ambitious mission and goals, and Pooya will continue to build the organization and bring it to the next level, providing strategic guidance and leadership for our in vitro diagnostic device R&D, regulatory approval, and commercialization teams.
Antimicrobial Resistance Point of Care Diagnostics Challenge
Sensoreal has been invited to submit a proposal by Canada’s Innovative Solutions program for Phase 2 of the Antimicrobial Resistance Point of Care Diagnostics Challenge.
Sensoreal has been invited to submit a proposal by Canada’s Innovative Solutions program for Phase 2 of the Antimicrobial Resistance Point of Care Diagnostics Challenge.
Canadian Food Inspection Agency project
Sensoreal celebrates the successful completion of Phase 1 of the Canadian Food Inspection Agency project to develop a biosensor device for the detection of Marine Biotoxins in Shellfish.
Sensoreal celebrates the successful completion of Phase 1 of the Canadian Food Inspection Agency project to develop a biosensor device for the detection of Marine Biotoxins in Shellfish.
Sensoreal completes Phase 1 of Innovative Solutions
Sensoreal completes Phase 1 of Innovative Solutions’s challenge in developing a Point of Care Diagnostic tool to help combat the rising incidence of Antimicrobial Resistance.
Sensoreal completes Phase 1 of Innovative Solutions’s challenge in developing a Point of Care Diagnostic tool to help combat the rising incidence of Antimicrobial Resistance.
Milestone 2 of the Canadian Space Agency project
Sensoreal successfully finishes Milestone 2 of the Canadian Space Agency project, finalizing the design of a microfluidic device with <10% CV, capable of operating in a zero gravity environment.
Sensoreal successfully finishes Milestone 2 of the Canadian Space Agency project, finalizing the design of a microfluidic device with <10% CV, capable of operating in a zero gravity environment.
Nick Georgiev joins Sensoreal
Nick Georgiev joins Sensoreal’s team as a Senior Scientist in Assay Development. Nick possesses extensive prior experience in immunology and host response diagnostic method development and validation.
Nick Georgiev joins Sensoreal’s team as a Senior Scientist in Assay Development. Nick possesses extensive prior experience in immunology and host response diagnostic method development and validation.
Loisa Guignard joins Sensoreal
Loisa Guignard joins Sensoreal as Senior Scientist, lending her biotechnology expertise to the growing team.
Loisa Guignard joins Sensoreal as Senior Scientist, lending her biotechnology expertise to the growing team.
Sensoreal expands its prototyping
Sensoreal expands its prototyping and manufacturing laboratory capability with the purchase of new equipment.
Sensoreal expands its prototyping and manufacturing laboratory capability with the purchase of new equipment.
Sensoreal relocates operations
Sensoreal relocates operations to a spacious new facility in Montreal’s picturesque Mile-Ex. The expanded office and laboratory space will allow for a more streamlined product development.
Sensoreal relocates operations to a spacious new facility in Montreal’s picturesque Mile-Ex. The expanded office and laboratory space will allow for a more streamlined product development.
Sensoreal selected by NEXT Canada program
Sensoreal CEO Roozbeh Safavieh & Pooya Saberi have been selected as part of the NEXT Canada program to discover and support the most promising entrepreneurs in 2020.
Sensoreal CEO Roozbeh Safavieh & Pooya Saberi have been selected as part of the NEXT Canada program to discover and support the most promising entrepreneurs in 2020. Link
Sensoreal safety protocols during COVID-19
Sensoreal has reviewed and updated its health and safety protocols in order to ensure safe working conditions during the COVID-19 pandemic. Providing a secure work environment is a paramount objective for Sensoreal.
Sensoreal has reviewed and updated its health and safety protocols in order to ensure safe working conditions during the COVID-19 pandemic. Providing a secure work environment is a paramount objective for Sensoreal.
Sensoreal development of a Point of Care diagnostic device
Sensoreal is excited to announce that the company has begun working on the development of a Point of Care diagnostic device capable of differentiating between bacterial and viral infections. This project has been partially funded by Canada’s Innovative Solutions, answering the challenge to develop tools to combat the rise of Antimicrobial Resistance (AMR).
Sensoreal is excited to announce that the company has begun working on the development of a Point of Care diagnostic device capable of differentiating between bacterial and viral infections. This project has been partially funded by Canada’s Innovative Solutions, answering the challenge to develop tools to combat the rise of Antimicrobial Resistance (AMR). Link
Sensoreal awarded a contract from Canadian Food Inspection Agency
Sensoreal has been awarded a contract from Canadian Food Inspection Agency to develop a biosensor platform to detect Marine Biotoxin Detection Devices for Shellfish.
Sensoreal has been awarded a contract from Canadian Food Inspection Agency to develop a biosensor platform to detect Marine Biotoxin Detection Devices for Shellfish. Link
Sensoreal joins Creative Destruction Lab
Sensoreal has joined the Creative Destruction Lab.
Sensoreal has joined the Creative Destruction Lab.
Sensoreal welcomes Pooya Saberi
Sensoreal welcomes our new CPO, Pooya Saberi, M.Eng.
Sensoreal welcomes our new CPO, Pooya Saberi, M.Eng.
Sensoreal files patent
Sensoreal has filed a patent for the novel application of plasma polymer films to microfluidics.
Sensoreal has filed a patent for the novel application of plasma polymer films to microfluidics.